Myeloma Canada Research Network   Report issue

Academic/Hospital Phase 2
Founded: Vaughan Canada (2016)

Organization Overview

First Clinical Trial
2016
NCT02597062
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Myeloma Canada Research Network